Commonwealth Laboratories

Commonwealth Laboratories, Cedars-Sinai ink agreement

Friday, October 4, 2013

Commonwealth Laboratories, a diagnostic laboratory headquartered in Salem, Mass., and Cedars-Sinai Medical Center have signed an exclusive license agreement for three patents owned by Cedars-Sinai that cover technology developed by Mark Pimentel, M.D., FRCPC, director of Cedars-Sinai’s gastrointestinal motility program and laboratory, and Henry C. Lin, M.D. These patents describe the use of hydrogen and methane breath testing in the diagnosis of irritable bowel syndrome (IBS) and other disorders caused by small intestinal bacterial overgrowth (SIBO).

[Read More]